首页> 外文期刊>Southern Medical Journal >Aleukemic Myeloid Leukemia Cutis with a Kikuchi Disease-Like Inflammatory Pattern in Myelodysplastic Syndrome
【24h】

Aleukemic Myeloid Leukemia Cutis with a Kikuchi Disease-Like Inflammatory Pattern in Myelodysplastic Syndrome

机译:白血病骨髓性白血病与髓细胞增强综合征中的kikuchi病如kikuchi疾病炎症模式

获取原文
获取原文并翻译 | 示例
       

摘要

Myeloid leukemia cutis (MLC) is a rare disease characterized by the infiltration of neoplastic myeloid, myelomonocytic, or monocytic precursors into the skin, producing clinically nonspecific-appearing papules, nodules, plaques, or purpura that necessitate biopsy for definitive diagnosis. In general, it is considered an extramedullary manifestation of acute myeloid leukemia (AML) similar to myeloid sarcoma, also known as a chloroma. MLC often develops in patients with an established diagnosis of AML and is only rarely seen before the onset of systemic disease. Even more rarely, some patients are found to have an underlying nonleukemic bone marrow disease, such as a myelodysplastic syndrome (MDS). It is in these latter settings that the somewhat perplexing terminology aleukemic leukemia cutis (ALC) has been used widely. As may be imagined, establishing a diagnosis of ALC can be problematic and typically requires a high index of suspicion with careful integration of clinical, histopathological, and laboratory data. Once a diagnosis of ALC is made, a complete hematologic workup, including assessment of the patient's bone marrow, is essential because a diagnosis of MLC (with or without systemic leukemia) generally indicates a poor prognosis. When discovered in a patient with MDS, MLC has been suggested to herald progression toward more advanced disease. We present a rare case of so-called aleukemic myeloid leukemia cutis in an 82-year-old man subsequently diagnosed as having MDS without progression to overt AML. This case also illustrates a seemingly rare Kikuchi disease-like inflammatory pattern that obscured the underlying leukemic infiltrate in the skin, delaying its recognition.
机译:骨髓白血病Cutis(MLC)是一种罕见的疾病,其特征在于肿瘤骨髓,骨髓细胞或单核细胞前体浸润到皮肤中,在临床上产生临床非特异性出现的丘疹,结节,斑块或purpura,这需要活组织检查以用于确定性诊断。通常,它被认为是类似于骨髓肉瘤的急性髓性白血病(AML)的次要表现,也称为氯瘤。 MLC通常在患者患者患者中发育,并且在全身疾病发作之前只有很少见到。甚至更少,发现一些患者有潜在的非血糖骨髓疾病,如骨髓增生术综合征(MDS)。它在这些后一种环境中,若干令人困惑的术语Aleukemic Leukemia Cutis(ALC)被广泛使用。如可以想象的那样,建立ALC的诊断可能是有问题的,并且通常需要仔细融合临床,组织病理学和实验室数据的高度怀疑。一旦对ALC的诊断进行了诊断,完全血液学掉次疗法,包括评估患者的骨髓,是必不可少的,因为MLC(有或没有全身白血病)的诊断通常表明预后差。当在患有MDS的患者中发现时,已经提出了MLC对更晚期疾病的先驱进展。我们在82岁的男子中展示了一种罕见的血吸镜髓性白血病,随后被诊断为具有明显AML的没有进展而被诊断为MDS。这种情况还说明了看似罕见的kikuchi疾病样炎症模式,掩盖了皮肤中的潜在白血病浸润,延迟了其识别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号